ada.enesco, Author at European Medical Journal - Page 30 of 65

Persistent Fever Signals Higher Mortality in MRSA Bacteraemia

Persistent fever beyond 72 hours in patients with methicillin-resistant Staphylococcus aureus bacteraemia is strongly associated with increased mortality.

How Inflammatory Markers Influence Treatment Outcomes in Patients With GIST

A multicenter study has identified key prognostic factors in high-risk GIST patients, including preoperative inflammatory markers, mitotic index, and adherence to imatinib therapy.

Which Works Better for Acne: Spironolactone or Dapsone?

The findings suggest that topical spironolactone 5% gel is an effective and well-tolerated treatment for acne vulgaris.

SGLT2 Inhibitors Lower Kidney Failure Risk in Advanced Diabetes

A large-scale study in Taiwan has revealed that SGLT2 inhibitors significantly lower the risk of kidney failure in patients with Type 2 diabetes and CKD stage 5.

Body Size May Affect Kidney Donor Eligibility, Study Finds

A new study from the University of Minnesota suggests that differences in how kidney function is measured in living kidney donors could have significant long-term implications.

New Study Explores ctDNA in Urothelial Cancer Treatment

Researchers aimed to establish a plasma ctDNA sequencing assay and evaluate its effectiveness in assessing tumour genetics and treatment response.

Rezivertinib Outperforms Gefitinib in NSCLC Treatment Study

A Phase III trial has shown that rezivertinib offers superior progression-free survival compared to gefitinib as a first-line treatment in EGFR-mutated locally advanced or metastatic non-small-cell lung cancer.

Combined Ultrasound Technique Reliable for Ruling Out N2 Disease in Patients with Lung Cancer

Study shows combined endobronchial ultrasound and endoscopic ultrasound (CUS) is a highly reliable tool for ruling out N2 disease in patients with PET-negative lung cancer.

Antibiotic Resistance in Diabetes: New Research Reveals Concerning Trend

A recent study has uncovered a worrying link between diabetes and the rapid emergence of antibiotic resistance.

New Cambridge Study Reveals Vaccine Challenges for Immunocompromised Individuals

The study highlights the necessity of a third vaccination to detect neutralising activity, particularly against emerging Omicron subvariants.